Log In
Print
BCIQ
Print
Print this Print this
 

BI 224436

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionNon-catalytic site integrase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsHIV/AIDS
Regulatory Designation

Partner

Gilead Sciences Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today